Valion Bio (VBIO) news
Recent news
CPBIO renewal of continuing connected transactions, notice of special general meeting
Cancer Prevention & Biotechnology Limited (CPBIO) has announced the renewal of its continuing connected transactions, as disclosed in a recent regulatory filing. The company has also issued a notice of a special general meeting (SGM) to be held on October 30, 2026, for shareholders to consider and…
AInvest Wire · 2d agoCPBIO renewal of continuing connected transactions, notice of special general meeting
AInvest Wire · 2d agoValion Bio - May offer up to $100 mln of securities - SEC filing
Valion Bio, Inc. has filed with the U.S. Securities and Exchange Commission (SEC) to offer and sell up to $100 million of its securities, according to a recent SEC filing. The company did not specify the type of securities or the intended use of proceeds in the filing. However, such offerings are…
AInvest Wire · 7d agoValion Bio - Appoints Dean Zikria as interim CEO effective September 22, 2026 - SEC filing
Valion Bio, Inc. (NASDAQ:VBIO) has appointed Dean Zikria as interim CEO , according to a recent SEC filing. This follows the departure of former CEO Michael K. Handley and precedes the expanded leadership role of Lisa Wolf, who was appointed President and COO . Ms. Wolf continues to serve as Chief…
AInvest Wire · Sep 23, 2026Valion Bio Inc: Lisa Wolf appointed as president & chief operating officer; to continue to serve as CFO
AInvest Wire · Sep 1, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.